2018
DOI: 10.1093/ndt/gfy171
|View full text |Cite
|
Sign up to set email alerts
|

Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial

Abstract: Our result suggests the potential of FOS in reducing serum total and free PCS in nondiabetic NDD-CKD patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
47
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 68 publications
(51 citation statements)
references
References 38 publications
2
47
0
Order By: Relevance
“…It is worth mentioning that although our study had a shorter intervention time (4 weeks), the amount of RS administered per day was higher (16 g). In addition, Ramos et al did not observed reduction of IAA after supplementation with a prebiotic (FOS) in pre-dialysis patients, agreeing with our results 33 .…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…It is worth mentioning that although our study had a shorter intervention time (4 weeks), the amount of RS administered per day was higher (16 g). In addition, Ramos et al did not observed reduction of IAA after supplementation with a prebiotic (FOS) in pre-dialysis patients, agreeing with our results 33 .…”
Section: Discussionsupporting
confidence: 93%
“…IAA and uremic toxins relationship have been explored in the CKD 16 , 23 , 32 , 33 . In a clinical trial, IAA was associated with an increase in mortality and cardiovascular events in CKD patients with IAA levels > 3.73 µM when compared to patients with lower levels (IAA <= 3.73 µM).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, dietary fiber may delay gastric emptying, bind bile acid, compete with dietary protein as substrates for fermentation by the gut flora [41]. In this sense, a recent trial in CKD patients showed that increased fiber intake was similarly effective to pharmacological treatments in the management of constipation, a common complication of CKD [42]. Dietary fiber is also accompanied by increased vitamin intake and antioxidant intake, that can lead to lower endogenous production of acid, and reduced production of uremic toxins such as p-cresyl sulfate and indoxyl sulfate, two considered risk factors for accelerated CKD progression [43].…”
Section: Dietary Fibermentioning
confidence: 99%
“…Consumption of fermentable oligosaccharides by rats led to a decrease in blood urea [ 18 ]. In humans with non-dialysis-dependent CKD, a three-month, randomized, double-blind, placebo-controlled trial showed a reduction in the microbial-derived uremic toxin p-cresyl sulfate with the consumption of fructooligosaccharide [ 19 ]. In addition, a small study in which nine overweight beagles were given inulin-type fructans found changes in metabolites and the gut microbiome [ 20 ].…”
Section: Introductionmentioning
confidence: 99%